secwatch / observer
8-K filed December 15, 2025, 6:59 PM ET ticker MNTS CIK 0001781162
other material confidence high sentiment negative materiality 0.60

Momentus announces 1-for-17.85 reverse stock split to meet Nasdaq $1 bid price

Momentus Inc.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.98

Momentus Inc. issued common stock.

Security
common stock
Exact text from the filing
On December 3, 2025, the Board of Directors (the “Board”) of Momentus Inc., a Delaware corporation (the “Company”) approved a reverse stock split of the Company’s issued and outstanding shares of Class A Common Stock, $0.00001 par value per share (the “Common Stock”), at a ratio of 1-for-17.85 (the “Reverse Stock Split”). The Reverse Stock Split will be effective as of 5:00 p.m. Eastern Time on Wednesday, December 17, 2025 (the “Effective Date”), with the Common Stock trading on the Nasdaq Capital Market on a reverse-split adjusted basis under the Company’s existing trading symbol, “MNTS,” at the market open on Thursday, December 18, 2025.
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Momentus Inc.: Approved a 1-for-17.85 reverse stock split and will file a certificate of amendment to the certificate of incorporation to effect the split (effective 2025-12-17).

Change
charter amendment
Effective
2025-12-17
Exact text from the filing
The Company will effect the Reverse Stock Split pursuant to the Company’s filing of a certificate of amendment to the Company’s certificate of incorporation (the “Certificate”) with the Delaware Secretary of State effective 5:00 p.m. Eastern Time, on December 17, 2025
View on SEC.gov

Browse all equity issuances →

Momentus Inc. filing history →

Source: SEC EDGAR
accession 0001140361-25-045491
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.